Biogen Inc. (BIIB)

BIIB trades at $159.88, 11.0% above the near-term max pain of $144 expiring Oct 10, 2025 (5 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($125-$155), indicating stable market expectations. Key magnetic zone at 140 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for BIIB shows stable levels around 140.06, reflecting balanced market expectations. The 21% spread signals divergent expectations across timeframes. Most levels below 159.88 may cap rallies. Strong magnetic level at 140 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.